TEAD1 Knockdown Ameliorates Diabetic Erectile Dysfunction in Rats and Is Associated With Modulation of Calcium Signaling‐Mediated Contractile Machinery
Drug Development Research · 2026
DOI: 10.1002/ddr.70365 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, 2026. Verfasst von Tao Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, China. Hauptthemen laut MEDLINE: Erectile Dysfunction, Diabetes Mellitus, Experimental, Calcium Signaling, Transcription Factors. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Guangzhou Science and Technology Planning Project, National Natural Science Foundation of China.
Abstract (Originalsprache)
Diabetes mellitus (DM) related erectile dysfunction (ED) is a common complication in males. We aim to explore the specific regulatory mechanisms of TEA domain family member 1 (TEAD1) in DMED rats. Diabetic ED in rats was induced by streptozotocin and evaluated by the intracavernosal pressure response to electrical stimulation and the apomorphine test. Corpus cavernosum smooth muscle cells (CCSMCs) were isolated to explore the role of TEAD1 in phenotypic transformation. TEAD1 knockdown was performed in DMED rats and CCSMCs using the CRISPR/Cas9 technology. Hematoxylin–Eosin and Masson staining were applied to observe the penile tissue pathology. The CCSMC function was evaluated by detecting viability and apoptosis. Protein and gene expression levels were examined by Western blot and real‐time quantitative polymerase chain reaction. The TEAD1 gene knockdown ameliorated erectile function in DMED rats. Knockdown of TEAD1 in CCSMCs of DMED rats enhanced their viability and inhibited their apoptosis, promoting the transformation of CCSMCs from a synthetic to a contractile phenotype. Furthermore, bioinformatics analysis identified the calcium signaling pathway as a candidate pathway warranting further experimental investigation. TEAD1 knockdown was associated with altered expression of calcium‐related proteins and elevated intracellular Ca 2+ levels. The calcium channel blocker Nimodipine could reverse the improvement of erectile function in DMED rats and the transformation of CCSMC phenotype caused by TEAD1 knockdown. TEAD1 knockdown promotes the transformation of CCSMCs from a synthetic to a contractile phenotype and is associated with modulation of calcium signaling‐mediated contractile machinery, contributing to the relief of DMED.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Guangzhou Red Cross Hospital, Jinan University, Guangzhou, China.
- Department of Urology, Guangzhou Red Cross Hospital, Guangdong Medical University, Zhanjiang, China.
- Department of Urology, The Second School of Clinical Medicine, Southern Medical University, Guangdong Second Provincial General Hospital, Guangzhou, China.
- Department of Obstetrics and Gynecology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
ORCID-Profile: Tao Zhang
Förderung
- Guangzhou Science and Technology Planning Project
- National Natural Science Foundation of China
Zitieren
APA
Zhang, T., Wu, C., Lu, Y., Li, W., Zhang, H., & Li, C. (2026). TEAD1 Knockdown Ameliorates Diabetic Erectile Dysfunction in Rats and Is Associated With Modulation of Calcium Signaling‐Mediated Contractile Machinery. Drug Development Research. https://doi.org/10.1002/ddr.70365
Vancouver
Zhang T, Wu C, Lu Y, Li W, Zhang H, Li C. TEAD1 Knockdown Ameliorates Diabetic Erectile Dysfunction in Rats and Is Associated With Modulation of Calcium Signaling‐Mediated Contractile Machinery. Drug Development Research. 2026. doi:10.1002/ddr.70365
BibTeX
@article{Zhang2026,
author = {Zhang, Tao and Wu, Chenxiao and Lu, Youlong and Li, Weili and Zhang, Huaru and Li, Cheng},
title = {TEAD1 Knockdown Ameliorates Diabetic Erectile Dysfunction in Rats and Is Associated With Modulation of Calcium Signaling‐Mediated Contractile Machinery},
journal = {Drug Development Research},
year = {2026},
doi = {10.1002/ddr.70365}
}
EUVIMED